Search

Displaying results 8111 - 8120 of 10000 in total
  1. Drug

    Urefibrate

    go.drugbank.com/drugs/DB20849
    Experimental

    The usage of the INN stem '-fibrate' in the name indicates that Urefibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Urefibrate is a small molecule drug.

  2. Drug

    MK-8777

    go.drugbank.com/drugs/DB18904
    Investigational

    MK-8777 is under investigation in clinical trial NCT00610649 (Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder

  3. Drug

    DCFBC F-18

    go.drugbank.com/drugs/DB14772
    Investigational

    DCFBC F-18 is under investigation in clinical trial NCT02190279 (18F-DCFBC PET/CT in Prostate Cancer).

  4. Drug

    Modotuximab

    go.drugbank.com/drugs/DB14827
    Investigational

    Modotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab in Patients With mCRC).

  5. Drug

    Narnatumab

    go.drugbank.com/drugs/DB14964
    Investigational

    Narnatumab is under investigation in clinical trial NCT01119456 (A Study of IMC-RON8 in Advanced Solid Tumors).

  6. Drug

    Mureletecan

    go.drugbank.com/drugs/DB15020
    Investigational

    Mureletecan is under investigation in clinical trial NCT00004076 (PNU 166148 in Treating Patients With Metastatic Solid Tumors).

  7. Drug

    Hydrogen

    go.drugbank.com/drugs/DB15127
    Investigational

    Hydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function and Performance in Elderly).

  8. Drug

    Futuximab

    go.drugbank.com/drugs/DB15262
    Investigational

    Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).

  9. Drug

    Epalrestat

    go.drugbank.com/drugs/DB15293
    Investigational

    Epalrestat is under investigation in clinical trial NCT03244358 (Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer).

  10. Drug

    BI 44370 TA

    go.drugbank.com/drugs/DB16037
    Investigational

    BI 44370 TA is under investigation in clinical trial NCT00751803 (BI 44370 TA in Acute Migraine Attack).